company background image
QTM

Quantum Health GroupASX:QTM Stock Report

Market Cap

AU$79.0m

7D

0%

1Y

37.3%

Updated

16 Oct, 2021

Data

Company Financials
QTM fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends0/6

QTM Overview

Quantum Health Group Limited distributes medical imaging and patient treatment equipment and services in Australia, Thailand, Korea, the Philippines.

Price History & Performance

Summary of all time highs, changes and price drops for Quantum Health Group
Historical stock prices
Current Share PriceAU$0.07
52 Week HighAU$0.044
52 Week LowAU$0.10
Beta2.23
1 Month Change14.75%
3 Month Change16.67%
1 Year Change37.26%
3 Year Change218.18%
5 Year Change250.00%
Change since IPO-81.33%

Recent News & Updates

Sep 29
Quantum Health Group (ASX:QTM) Has A Rock Solid Balance Sheet

Quantum Health Group (ASX:QTM) Has A Rock Solid Balance Sheet

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Jul 20
Does Quantum Health Group (ASX:QTM) Deserve A Spot On Your Watchlist?

Does Quantum Health Group (ASX:QTM) Deserve A Spot On Your Watchlist?

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...

May 25
Quantum Health Group (ASX:QTM) Could Easily Take On More Debt

Quantum Health Group (ASX:QTM) Could Easily Take On More Debt

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Shareholder Returns

QTMAU HealthcareAU Market
7D0%-1.3%0.9%
1Y37.3%11.5%20.2%

Return vs Industry: QTM exceeded the Australian Healthcare industry which returned 11.5% over the past year.

Return vs Market: QTM exceeded the Australian Market which returned 20.2% over the past year.

Price Volatility

Is QTM's price volatile compared to industry and market?
QTM volatility
QTM Beta2.23
Industry Beta0.61
Market Beta1

Stable Share Price: QTM is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: QTM's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1975n/aJohn Walstabhttps://www.qhealthcare.com.au

Quantum Health Group Limited distributes medical imaging and patient treatment equipment and services in Australia, Thailand, Korea, the Philippines. It operates through two segments, Medical and Environmental Services. The company distributes medical products in the field of radiology, oncology, aesthetics, and environmental health.

Quantum Health Group Fundamentals Summary

How do Quantum Health Group's earnings and revenue compare to its market cap?
QTM fundamental statistics
Market CapAU$78.98m
Earnings (TTM)AU$6.82m
Revenue (TTM)AU$55.60m

11.6x

P/E Ratio

1.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
QTM income statement (TTM)
RevenueAU$55.60m
Cost of RevenueAU$26.65m
Gross ProfitAU$28.95m
ExpensesAU$22.13m
EarningsAU$6.82m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.006
Gross Margin52.06%
Net Profit Margin12.27%
Debt/Equity Ratio15.5%

How did QTM perform over the long term?

See historical performance and comparison

Valuation

Is Quantum Health Group undervalued compared to its fair value and its price relative to the market?

20.7%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: QTM (A$0.07) is trading below our estimate of fair value (A$0.09)

Significantly Below Fair Value: QTM is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: QTM is good value based on its PE Ratio (11.6x) compared to the Australian Healthcare industry average (25.4x).

PE vs Market: QTM is good value based on its PE Ratio (11.6x) compared to the Australian market (19.8x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate QTM's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: QTM is good value based on its PB Ratio (1.9x) compared to the AU Healthcare industry average (2.1x).


Future Growth

How is Quantum Health Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

2.0%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Quantum Health Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Quantum Health Group performed over the past 5 years?

57.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: QTM has high quality earnings.

Growing Profit Margin: QTM's current net profit margins (12.3%) are higher than last year (9.2%).


Past Earnings Growth Analysis

Earnings Trend: QTM has become profitable over the past 5 years, growing earnings by 57.4% per year.

Accelerating Growth: QTM's earnings growth over the past year (25.2%) is below its 5-year average (57.4% per year).

Earnings vs Industry: QTM earnings growth over the past year (25.2%) underperformed the Healthcare industry 61.3%.


Return on Equity

High ROE: QTM's Return on Equity (16.3%) is considered low.


Financial Health

How is Quantum Health Group's financial position?


Financial Position Analysis

Short Term Liabilities: QTM's short term assets (A$40.6M) exceed its short term liabilities (A$26.2M).

Long Term Liabilities: QTM's short term assets (A$40.6M) exceed its long term liabilities (A$898.0K).


Debt to Equity History and Analysis

Debt Level: QTM's debt to equity ratio (15.5%) is considered satisfactory.

Reducing Debt: QTM's debt to equity ratio has reduced from 67.2% to 15.5% over the past 5 years.

Debt Coverage: QTM's debt is well covered by operating cash flow (95.6%).

Interest Coverage: QTM's interest payments on its debt are well covered by EBIT (13.9x coverage).


Balance Sheet


Dividend

What is Quantum Health Group current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate QTM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate QTM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if QTM's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if QTM's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of QTM's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

11.0yrs

Average board tenure


CEO

John Walstab (58 yo)

4.67yrs

Tenure

AU$308,294

Compensation

Mr. John Andrew Walstab has been Managing Director of Quantum Health Group Limited (formerly known as Quantum Energy Limited) since February 7, 2017 and serves as its Chief Executive Officer and Company Se...


CEO Compensation Analysis

Compensation vs Market: John's total compensation ($USD228.82K) is about average for companies of similar size in the Australian market ($USD302.45K).

Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.


Board Members

Experienced Board: QTM's board of directors are seasoned and experienced ( 11 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Quantum Health Group Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Quantum Health Group Limited
  • Ticker: QTM
  • Exchange: ASX
  • Founded: 1975
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: AU$78.982m
  • Shares outstanding: 1.13b
  • Website: https://www.qhealthcare.com.au

Number of Employees


Location

  • Quantum Health Group Limited
  • 22 Rosebery Avenue
  • Rosebery
  • New South Wales
  • 2018
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/16 07:04
End of Day Share Price2021/10/15 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.